Log In
Print this Print this

Diacol, OsmoPrep (INKP-102)

  Manage Alerts
Collapse Summary General Information
Company Valeant Pharmaceuticals International Inc.
DescriptionSecond-generation sodium phosphate purgative
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationConstipation
Indication DetailsCleanse bowel prior to colonoscopy
Regulatory Designation
PartnerDr. Falk Pharma GmbH

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today